Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort

Abstract

Poor immunological recovery despite virological successful HAART is associated with a higher risk for overall morbidity and mortality and CVEs in particular. This study underlines the importance of starting HAART at higher CD4 cell counts, particularly in older patients.